Authors:
FUJII S
FUJIMOTO K
OSATO M
MATSUI K
TAKATSUKI K
KAWAKITA M
Citation: S. Fujii et al., INDUCTION OF ANTITUMOR CYTOTOXIC ACTIVITY USING CD34(-DERIVED AND IRRADIATED TUMOR CELL-PRIMED DENDRITIC CELLS() CORD BLOOD CELL), International journal of hematology, 68(2), 1998, pp. 169-182
Authors:
OSATO M
GRAHAM DY
VAKIL N
GORDON SH
KLEOUDIS CS
SILVER MT
MURDOCK RH
Citation: M. Osato et al., DEVELOPMENT OF CLARITHROMYCIN RESISTANCE IS 2.7 TIMES LESS LIKELY WITH RANITIDINE BISMUTH CITRATE THAN WITH OMEPRAZOLE, Gastroenterology, 114(4), 1998, pp. 1022-1022
Authors:
ASOU N
OSATO M
ABDALLA E
HOSHINO K
YAMASAKI H
OKUBO T
ERA T
SUZUSHIMA H
TAKATSUKI K
Citation: N. Asou et al., POINT MUTATIONS IN THE RUNT DOMAIN OF THE AML1 GENE IN MYELOBLASTIC-LEUKEMIA CELLS, British Journal of Haematology, 102(1), 1998, pp. 14-14
Authors:
HOSHINO K
ASOU N
SUZUSHIMA H
OSATO M
YAMASAKI H
OKUBO T
NISHIMURA S
KIYOKAWA T
KAWANO F
TAKATSUKI K
Citation: K. Hoshino et al., TEL AML1-FUSION GENE RESULTING FROM A CRYPTIC T(12-21) IS UNCOMMON INADULT PATIENTS WITH B-CELL LINEAGE ALL AND CML-LYMPHOBLASTIC TRANSFORMATION/, International journal of hematology, 66(2), 1997, pp. 213-218
Authors:
ASOU N
OSATO M
HORIKAWA K
NISHIKAWA K
SAKITANI O
LI L
YAMASAKI H
NISHIMURA S
OKUBO T
SUZUSHIMA H
TAKATSUKI K
Citation: N. Asou et al., BURKITTS TYPE ACUTE LYMPHOBLASTIC TRANSFORMATION ASSOCIATED WITH T(8-14) IN A CASE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 11(11), 1997, pp. 1986-1988
Authors:
OSATO M
ASOU N
TAKATA N
SUZUSHIMA H
TAKATSUKI K
KAWANO F
Citation: M. Osato et al., DETECTION OF THE PEBP2-BETA MYH11 FUSION TRANSCRIPT IN ACUTE MYELOMONOBLASTIC LEUKEMIA (M4EO) SUPERVENING IN A PATIENT WITH ADULT T-CELL LEUKEMIA/, American journal of hematology, 55(4), 1997, pp. 216-217
Authors:
GRAHAM DY
HOFFMAN J
ELZIMAITY HMT
GRAHAM DP
OSATO M
Citation: Dy. Graham et al., TWICE A DAY QUADRUPLE THERAPY (BISMUTH SUBSALICYLATE, TETRACYCLINE, METRONIDAZOLE PLUS LANSOPRAZOLE) FOR TREATMENT OF HELICOBACTER-PYLORI INFECTION, Alimentary pharmacology & therapeutics, 11(5), 1997, pp. 935-938
Authors:
BREUER T
KIM JG
ELZIMAITY HMT
NIKAJIMA S
OTA H
OSATO M
GRAHAM DY
Citation: T. Breuer et al., CLARITHROMYCIN, AMOXICILLIN AND H-2-RECEPTOR ANTAGONIST THERAPY FOR HELICOBACTER-PYLORI PEPTIC-ULCER DISEASE IN KOREA, Alimentary pharmacology & therapeutics, 11(5), 1997, pp. 939-942
Authors:
BREUER T
KIM JG
GURER IE
GRAHAM DP
OSATO M
GENTA RM
GRAHAM DY
Citation: T. Breuer et al., SUCCESSFUL LOW-DOSE AMOXICILLIN, METRONIDAZOLE AND OMEPRAZOLE COMBINATION THERAPY IN A POPULATION WITH A HIGH-FREQUENCY OF METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI, Alimentary pharmacology & therapeutics, 11(3), 1997, pp. 523-527
Authors:
MALATY HM
BERENSON GS
WATTINGTON WA
SATHANUR SR
OSATO M
YUKSEL M
GRAHAM DY
Citation: Hm. Malaty et al., HELICOBACTER-PYLORI ACQUISITION IN CHILDHOOD - A 15-YEAR FOLLOW-UP COHORT STUDY IN A BI-RACIAL COMMUNITY, Gut, 41, 1997, pp. 33-33
Authors:
BABIAKVAZQUEZ AE
SEGURA AM
GENTA RM
GRAHAM DY
SAMPLE D
STEINBACH G
GUTIERREZ O
OSATO M
GO MF
Citation: Ae. Babiakvazquez et al., VARIABILITY IN PREVALENCE OF HELICOBACTER-PYLORI INFECTION IN INTESTINAL VS. DIFFUSE TYPES OF GASTRIC ADENOCARCINOMA, Gut, 41, 1997, pp. 50-50
Authors:
FEDORAK R
ARCHAMBAULT A
FLAMM R
OSATO M
STAMLER D
Citation: R. Fedorak et al., ANTIMICROBIAL SUSCEPTIBILITY OF HELICOBACTER-PYLORI IN CANADA TO 3 KEY ANTIBIOTICS - METRONIDAZOLE, CLARITHROMYCIN, AND AMOXICILLIN, Gastroenterology, 112(4), 1997, pp. 115-115
Authors:
GRAHAM DY
HOFFMAN J
ELZIMAITY HMT
GRAHAM DP
GENTA RM
OSATO M
Citation: Dy. Graham et al., TWICE A DAY QUADRUPLE THERAPY (BISMUTH SUBSALICYLATE, TETRACYCLINE, METRONIDAZOLE, PLUS LANSOPRAZOLE) FOR TREATMENT OF HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 132-132
Citation: H. Mann et al., A COMPARISON OF ETEST(R) TO AGAR DILUTION IN DETECTING INTERMEDIATE AND BORDERLINE RESISTANT SUSCEPTIBILITIES TO CLARITHROMYCIN IN HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 209-209
Authors:
LEE JE
LU M
MANSFIELD PF
REVEILLE JD
SAMPLE D
OSATO M
BABIAKVAZQUEZ A
GLOBER GA
LYNCH PM
STEINBACH G
Citation: Je. Lee et al., GENOMIC HLA-DQB1-ASTERISK-0301 STATUS PREDICTS THE SEROLOGIC RESPONSETO HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH GASTROINTESTINAL MALIGNANCY, Gastroenterology, 112(4), 1997, pp. 1024-1024
Authors:
OSATO M
ASOU N
OKUBO T
NISHIMURA S
YAMASAKI H
ERA T
SUZUSHIMA H
KAWANO F
MATSUOKA R
OKA H
BAE SC
ITO Y
TAKATSUKI K
Citation: M. Osato et al., MYELOMONOBLASTIC LEUKEMIA-CELLS CARRYING THE PEBP2-BETA MYH11 FUSION GENE ARE CD34(+), C-KIT+ IMMATURE CELLS/, British Journal of Haematology, 97(3), 1997, pp. 656-658
Authors:
OSATO M
YAMAGUCHI K
TAMIYA S
YAMASAKI H
OKUBO T
SUZUSHIMA H
ASOU N
SAKATA K
KAWAKITA M
TAKATSUKI K
Citation: M. Osato et al., A HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I CARRIER WITH CHRONIC-RENAL-FAILURE, APLASTIC-ANEMIA, MYELOPATHY, UVEITIS, SJOGRENS-SYNDROME AND PANNICULITIS, Internal medicine, 35(9), 1996, pp. 742-745
Authors:
REDDY R
OSATO M
GUTIERREZ O
KIM JG
GRAHAM DY
Citation: R. Reddy et al., METRONIDAZOLE RESISTANCE IS HIGH IN KOREA END COLOMBIA AND APPEARS TOBE RAPIDLY INCREASING IN THE US, Gastroenterology, 110(4), 1996, pp. 238-238
Authors:
NISHIMURA S
ASOU N
SUZUSHIMA H
OKUBO T
FUJIMOTO T
OSATO M
YAMASAKI H
LISHA L
TAKATSUKI K
Citation: S. Nishimura et al., P53 GENE MUTATION AND LOSS OF HETEROZYGOSITY ARE ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION IN ADULT T-CELL LEUKEMIA, Leukemia, 9(4), 1995, pp. 598-604